Skip to main content

Tissue-engineering the tumour microenvironment to improve treatment of pancreatic cancer

Project description

Patient-derived in vitro models of pancreatic cancer

Pancreatic cancer is associated with an extremely poor prognosis, necessitating the development of novel therapies. This requires patient-specific models that mimic the biology of the tumour and the interaction between cancer and cancer-supporting cells. To address this issue, the EU-funded CHIPIN project proposes to develop 3D cancer models using tissue engineering and bioprinting. The built platforms will consist of hydrogels, extracellular matrix molecules and patient-derived cells and will recreate the biomechanical characteristics of the pancreatic tumour microenvironment. This new approach will offer a clinically relevant platform for screening novel therapies.

Call for proposal

ERC-2019-COG
See other projects for this call

Host institution

LEIBNIZ-INSTITUT FUR POLYMERFORSCHUNG DRESDEN EV
Address
Hohe Strasse 6
01069 Dresden
Germany

See on map

Activity type
Research Organisations
EU contribution
€ 2 000 000

Beneficiaries (1)

LEIBNIZ-INSTITUT FUR POLYMERFORSCHUNG DRESDEN EV
Germany
EU contribution
€ 2 000 000
Address
Hohe Strasse 6
01069 Dresden

See on map

Activity type
Research Organisations